Active ingredient
Hyaluronidase (Human recombinant) NDC Codes
Hyaluronidase (Human recombinant) is an active ingredient in 18 finished products listed with the FDA, under 11 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Rybrevant Faspro, VYVGART Hytrulo, Opdivo Qvantig, Phesgo, Rituxan Hycela, Ocrevus Zunovo, Tecentriq Hybreza, Hyaluronidase, Darzalex Faspro, Herceptin Hylecta, HYLENEX Recombinant
- Labelers
- Genentech, Inc., Janssen Biotech, Inc., argenx US, E.R. Squibb & Sons, L.L.C., HF Acquisition Co LLC, DBA HealthFirst, Antares Pharma, Inc.
- Strengths
- Hyaluronidase (Human recombinant) 2000 U/mL; Hyaluronidase (Human recombinant) 30000 U/15mL; Nivolumab 120 mg/mL; Hyaluronidase (Human recombinant) 150 [USP'U]/mL; Rituximab 120 mg/mL; Amivantamab 2400 mg/15mL; Hyaluronidase (Human recombinant) 30000 mg/15mL; Amivantamab 3520 mg/22mL; Hyaluronidase (Human recombinant) 44000 mg/22mL; Amivantamab 1600 mg/10mL; Hyaluronidase (Human recombinant) 20000 mg/10mL; Amivantamab 2240 mg/14mL; Hyaluronidase (Human recombinant) 28000 mg/14mL; Efgartigimod alfa 200 mg/mL; Ocrelizumab 920 mg/23mL; Hyaluronidase (Human recombinant) 23000 U/23mL; Atezolizumab 1875 mg/15mL; Efgartigimod alfa 180 mg/mL; Pertuzumab 1200 mg/15mL; Trastuzumab 600 mg/15mL
- Dosage forms
- Injection, Solution, Injection
- Routes
- Subcutaneous
- Drug classes (FDA established)
- Endoglycosidase, HER2/neu Receptor Antagonist, Programmed Death Receptor-1 Blocking Antibody, CD20-directed Cytolytic Antibody, Neonatal Fc Receptor Blocker, CD38-directed Cytolytic Antibody
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 24
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2400 mg/15mL; Hyaluronidase (Human recombinant) 30000 mg/15mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-515 | 57894-0515-01 | — |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 3520 mg/22mL; Hyaluronidase (Human recombinant) 44000 mg/22mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-522 | 57894-0522-01 | — |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 1600 mg/10mL; Hyaluronidase (Human recombinant) 20000 mg/10mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-510 | 57894-0510-01 | — |
| Rybrevant Fasproamivantamab and hyaluronidase-lpuj (human recombinant) | Amivantamab 2240 mg/14mL; Hyaluronidase (Human recombinant) 28000 mg/14mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-514 | 57894-0514-01 | — |
| VYVGART Hytruloefgartigimod alfa and hyaluronidase (human recombinant) | Efgartigimod alfa 200 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | argenx US | 73475-1221 | 73475-1221-0173475-1221-04 | — |
| Opdivo Qvantignivolumab and hyaluronidase-nvhy | Nivolumab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | E.R. Squibb & Sons, L.L.C. | 0003-6120 | 00003-6120-01 | — |
| Opdivo Qvantignivolumab and hyaluronidase-nvhy | Nivolumab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | E.R. Squibb & Sons, L.L.C. | 0003-3120 | 00003-3120-01 | — |
| Ocrevus Zunovoocrelizumab and hyaluronidase | Ocrelizumab 920 mg/23mL; Hyaluronidase (Human recombinant) 23000 U/23mL | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-554 | 50242-0554-0150242-0554-86 | — |
| Tecentriq Hybrezaatezolizumab and hyaluronidase-tqjs | Atezolizumab 1875 mg/15mL; Hyaluronidase (Human recombinant) 30000 U/15mL | InjectionSubcutaneous | Genentech, Inc. | 50242-933 | 50242-0933-0150242-0933-86 | — |
| VYVGART Hytruloefgartigimod alfa and hyaluronidase (human recombinant) | Efgartigimod alfa 180 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | argenx US | 73475-3102 | 73475-3102-03 | — |
| Hyaluronidase | Hyaluronidase (Human recombinant) 150 [USP'U]/mL | Injection, SolutionSubcutaneous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1555 | 51662-1555-01 | — |
| Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf | Pertuzumab 1200 mg/15mL + 2 more ingredients | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-245 | 50242-0245-0150242-0245-86 | — |
| Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf | Pertuzumab 600 mg/10mL + 2 more ingredients | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-260 | 50242-0260-0150242-0260-86 | — |
| Darzalex Fasprodaratumumab and hyaluronidase-fihj (human recombinant) | Daratumumab 1800 mg/15mL; Hyaluronidase (Human recombinant) 30000 U/15mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-503 | 57894-0503-01 | — |
| Herceptin Hylectatrastuzumab and hyaluronidase-oysk | Trastuzumab 600 mg/5mL; Hyaluronidase (Human recombinant) 10000 U/5mL | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-077 | 50242-0077-01 | — |
| Rituxan Hycelarituximab and hyaluronidase | Rituximab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-108 | 50242-0108-0150242-0108-86 | — |
| Rituxan Hycelarituximab and hyaluronidase | Rituximab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-109 | 50242-0109-01 | — |
| HYLENEX Recombinanthyaluronidase | Hyaluronidase (Human recombinant) 150 [USP'U]/mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 18657-117 | 18657-0117-04 | — |
Hyaluronidase (Human recombinant): common questions
- Which drugs contain Hyaluronidase (Human recombinant)?
- Rybrevant Faspro, VYVGART Hytrulo, Opdivo Qvantig, Phesgo, Rituxan Hycela, Ocrevus Zunovo, Tecentriq Hybreza, Hyaluronidase, and others listed above.
- Is there a J-code for Hyaluronidase (Human recombinant)?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.